SOPHiA GENETICS (SOPH) Short-term Investments (2020 - 2023)

SOPHiA GENETICS (SOPH) has 4 years of Short-term Investments data on file, last reported at $1.1 million in Q1 2023.

• For the quarter ending Q1 2023, Short-term Investments fell 98.19% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2023 stood at $1.1 million (down 98.19% YoY), and the FY2022 full-year result was $17.3 million, down 76.08% from the prior year.
• Short-term Investments retreated to $1.1 million in Q1 2023, from $17.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $72.4 million in Q4 2021 to a low of $1.1 million in Q1 2023.
• A 4-year average of $37.3 million and a median of $31.4 million in 2022 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 218.47% in 2021 and slumped 98.19% in 2023, its largest moves.
• Tracing SOPH's Short-term Investments over 4 years: stood at $22.7 million in 2020, then jumped by 218.47% to $72.4 million in 2021, then plunged by 76.08% to $17.3 million in 2022, then slumped by 93.68% to $1.1 million in 2023.
• Business Quant data shows SOPH's Short-term Investments at $1.1 million in Q1 2023, $17.3 million in Q4 2022, and $31.4 million in Q3 2022.